NO970602L - Dimere DTPA-derivater og deres metallkomplekser, farmasöytiske midler inneholdende kompleksene, deres anvendelse ved diagnostikk og terapi, samt fremgangsmåter for fremstilling av kompleksene og midlene - Google Patents

Dimere DTPA-derivater og deres metallkomplekser, farmasöytiske midler inneholdende kompleksene, deres anvendelse ved diagnostikk og terapi, samt fremgangsmåter for fremstilling av kompleksene og midlene

Info

Publication number
NO970602L
NO970602L NO970602A NO970602A NO970602L NO 970602 L NO970602 L NO 970602L NO 970602 A NO970602 A NO 970602A NO 970602 A NO970602 A NO 970602A NO 970602 L NO970602 L NO 970602L
Authority
NO
Norway
Prior art keywords
complexes
diagnostics
methods
dimeric
agents
Prior art date
Application number
NO970602A
Other languages
English (en)
Other versions
NO970602D0 (no
Inventor
Werner Krause
Franz-Karl Maier
Michael Bauer
Wolf-Ruediger Press
Gabriele Schuhmann-Giampieri
Johannes Platzek
Heribert Schmitt-Willich
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO970602D0 publication Critical patent/NO970602D0/no
Publication of NO970602L publication Critical patent/NO970602L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A61K51/048—DTPA (diethylenetriamine tetraacetic acid)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nye dimere DTPA-derivater, deres metallkomplekser, inneholdende minst ett lon av et grunnstoff med ordenstall 21-32, 37-39, 42-51 og 57-84, midler inneholdende disse komplekser, deres anvendelse i IWR- og/eller røntgen- diagnostikk, radiodiagnostikk og radio- terapi, så vel som fremgangsmåter for fremstilling av slike.
NO970602A 1994-08-08 1997-02-10 Dimere DTPA-derivater og deres metallkomplekser, farmasöytiske midler inneholdende kompleksene, deres anvendelse ved diagnostikk og terapi, samt fremgangsmåter for fremstilling av kompleksene og midlene NO970602L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4428874A DE4428874A1 (de) 1994-08-08 1994-08-08 Dimere DTPA-Derivate und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
PCT/EP1995/003142 WO1996005167A1 (de) 1994-08-08 1995-08-08 Dimere dtpa-derivate und deren metallkomplexe, diese komplexe enthaltende pharmazeutische mittel, deren verwendung in der diagnostik und therapie sowie verfahren zur herstellung der komplexe und mittel

Publications (2)

Publication Number Publication Date
NO970602D0 NO970602D0 (no) 1997-02-10
NO970602L true NO970602L (no) 1997-02-10

Family

ID=6525715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970602A NO970602L (no) 1994-08-08 1997-02-10 Dimere DTPA-derivater og deres metallkomplekser, farmasöytiske midler inneholdende kompleksene, deres anvendelse ved diagnostikk og terapi, samt fremgangsmåter for fremstilling av kompleksene og midlene

Country Status (21)

Country Link
US (1) US5695737A (no)
EP (1) EP0775104B1 (no)
JP (1) JPH10503777A (no)
KR (1) KR970704668A (no)
AT (1) ATE179696T1 (no)
AU (1) AU695878B2 (no)
CA (1) CA2197074A1 (no)
CZ (1) CZ40597A3 (no)
DE (2) DE4428874A1 (no)
DK (1) DK0775104T3 (no)
ES (1) ES2134487T3 (no)
FI (1) FI970535A7 (no)
GR (1) GR3030827T3 (no)
HU (1) HUT77532A (no)
IL (1) IL114858A0 (no)
MX (1) MX9701080A (no)
NO (1) NO970602L (no)
PL (1) PL318503A1 (no)
SK (1) SK17397A3 (no)
WO (1) WO1996005167A1 (no)
ZA (1) ZA956650B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770261B2 (en) 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US6713045B1 (en) 1995-06-02 2004-03-30 Research Corporation Technologies, Inc. Targeted magnetic resonance imaging agents for the detection of physiological processes
US5900228A (en) 1996-07-31 1999-05-04 California Institute Of Technology Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
IT1290417B1 (it) * 1996-08-02 1998-12-03 Bracco Spa Composti chelanti derivati di acidi poliamminopolicarbossilici, loro chelati con ioni metallici paramagnetici, loro preparazione ed
DE19646762B4 (de) * 1996-11-04 2004-05-13 Schering Ag Verwendung von Metallverbindungen zur Herstellung von Mitteln zur Strahlentherapie von Tumoren
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
EP1032430A2 (en) 1997-11-17 2000-09-06 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
AU2001276956A1 (en) 2000-07-17 2002-01-30 California Institute Of Technology Macrocyclic mri contrast agents
AU2002211517A1 (en) 2000-10-04 2002-04-15 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
US4915933A (en) * 1986-06-26 1990-04-10 The University Of New Mexico Mixed complexes as shift and contrast reagents in NMR imaging and spectroscopy
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
DE3710730A1 (de) * 1987-03-31 1988-10-20 Schering Ag Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5482700A (en) * 1987-03-31 1996-01-09 Schering Aktiengesellschaft Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast
DE3728525A1 (de) * 1987-08-24 1989-03-16 Schering Ag Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
FR2652004B1 (fr) * 1989-09-21 1994-10-28 Immunotech Partners Nouveaux derives hydrophiles, application au diagnostic et a la therapeutique, kits diagnostiques ou therapeutiques et reactifs immunologiques.
US5244816A (en) * 1989-10-11 1993-09-14 Akzo N.V. Method for purifying chelator conjugated compounds
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
CA2069886A1 (en) * 1989-10-23 1991-04-24 David Love Multi-site metal chelating agents
WO1992005804A1 (en) * 1990-09-27 1992-04-16 Brunswick Corporation Chelating agents
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
US5466439A (en) * 1992-11-12 1995-11-14 Magnetic Research, Inc. Polymeric contrast enhancing agents for magnetic resonance images
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images

Also Published As

Publication number Publication date
DE59505856D1 (de) 1999-06-10
US5695737A (en) 1997-12-09
PL318503A1 (en) 1997-06-23
MX9701080A (es) 1997-05-31
EP0775104A1 (de) 1997-05-28
ATE179696T1 (de) 1999-05-15
NO970602D0 (no) 1997-02-10
FI970535A0 (fi) 1997-02-07
AU3343395A (en) 1996-03-07
CZ40597A3 (en) 1997-07-16
EP0775104B1 (de) 1999-05-06
HUT77532A (hu) 1998-05-28
IL114858A0 (en) 1995-12-08
WO1996005167A1 (de) 1996-02-22
KR970704668A (ko) 1997-09-06
DK0775104T3 (da) 2000-01-03
GR3030827T3 (en) 1999-11-30
ES2134487T3 (es) 1999-10-01
JPH10503777A (ja) 1998-04-07
CA2197074A1 (en) 1996-02-22
ZA956650B (en) 1996-03-19
DE4428874A1 (de) 1996-02-22
AU695878B2 (en) 1998-08-27
SK17397A3 (en) 1997-11-05
FI970535A7 (fi) 1997-02-07

Similar Documents

Publication Publication Date Title
NO972460D0 (no) Nye substituerte DTPA-derivater, deres metallkomplekser, farmasöytiske midler inneholdende metallkompleksene samt deres anvendelse ved diagnostikk og terapi
Schaap et al. The therapeutic relationship in behavioural psychotherapy.
NO970602L (no) Dimere DTPA-derivater og deres metallkomplekser, farmasöytiske midler inneholdende kompleksene, deres anvendelse ved diagnostikk og terapi, samt fremgangsmåter for fremstilling av kompleksene og midlene
NO301584B1 (no) Benzokondenserte 5-ringheterocykler, deres anvendelse til fremstilling av medikament og diagnostikum, samt medikamenter inneholdende disse
BR9803198B1 (pt) composto, processos para preparar o mesmo e para combater fungo ou uma doenÇa féngica de plantas em um local, e, composiÇço.
BR9612436A (pt) Método de contenção de radiação pelo uso de moléculas de fulereno.
MX26415A (es) Piridin-m-oxidos sustituidos en posiciones 2,4 y 2,5, procedimiento para su preparacion asi como su empleo
Huang et al. The effect of collimator backscatter radiation on photon output of linear accelerators
NO982181L (no) Type IX collagen og chimerer
DE68905705D1 (de) Sphaerische phosphoraggregate, ihre herstellung und verwendung in roentgenstrahlschirmen.
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
Target The problem of outcome in child psychoanalysis: Contributions from the Anna Freud Centre.
ATE106752T1 (de) Sichtbarmachung von tumoren mit technetiummarkierten kohlenhydraten.
Lutz et al. The effect of flattening filter design on quality variations within an 8‐MV primary x‐ray beam
Daglio Effects of Heat Treatment and Microcleanliness on Fatigue Properties of Steel Strips for Springs
NO891937D0 (no) Nye 6-fenoksymetyl-4-hydroksytetrahydropyran-2-on og 6-tiofenoksymetyl-4-hydroksytetrahydropyran-2-on, samt dihydroksykarboksylsyrederivater, salter og estere derav og fremg. for fremst. derav samt nye fenoler og tiofenoler.
DE59206361D1 (de) Behältertür für eine Sauerstoffversorgungseinheit
Nemirovskii et al. An Anomaly of the alpha'/ epsilon, gamma Orientation Relation in a Dual-Phase Alloy G 20
Seppälä et al. Establishing dose planning in BNCT at the Finnish facility
Assembly Concerning Health Care Coverage Parity for Neurobiologically Based Mental Illnesses.
HUT40784A (en) Process for the swelling or heat treatment of silicate-based materials, particularly pearlite
IT8834061V0 (it) Telaio per il supporto degli organi di controllo e di indicazione nelle macchine per il trattamento della biancheria.
DE59300169D1 (de) Verfahren zum Verdampfen und Anwärmen von flüssigem Wasserstoff, flüssigem Helium oder flüssigem Neon.
ITMI940598A0 (it) Telaio di supporto per la realizzazione di pareti trasparenti, semitrasparenti luci o simili
Rapaport Nuclear Spin Longitudinal Response